GEOVAX LABS, INC. Adjustments to Additional Paid in Capital, Convertible Debt with Conversion Feature
GEOVAX LABS, INC. (GOVX) reported Adjustments to Additional Paid in Capital, Convertible Debt with Conversion Feature of $762.67 thousand for the 12-month period ending 2013-12-31, per its 10-K filed 2014-03-14.
Discontinued › Shareholders' Equity › Adjustments to Additional Paid in Capital
us-gaap:AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature · last filed 2014-03-14
- GEOVAX LABS, INC. adjustments to additional paid in capital, convertible debt with conversion feature for the quarter ending 2012-12-31 was $0.00.
- GEOVAX LABS, INC. adjustments to additional paid in capital, convertible debt with conversion feature for the quarter ending 2012-09-30 was $0.00.
- GEOVAX LABS, INC. adjustments to additional paid in capital, convertible debt with conversion feature for the quarter ending 2012-06-30 was $762.67K.
- GEOVAX LABS, INC. adjustments to additional paid in capital, convertible debt with conversion feature for fiscal 2013 was $762.67K.
| Period end | Adjustments to Additional Paid in Capital, Convertible Debt with Conversion Feature 3 month | Adjustments to Additional Paid in Capital, Convertible Debt with Conversion Feature 6 month | Adjustments to Additional Paid in Capital, Convertible Debt with Conversion Feature 9 month | Adjustments to Additional Paid in Capital, Convertible Debt with Conversion Feature 12 month |
|---|---|---|---|---|
| 2013-12-31 | $762.67K 10-K · filed 2014-03-14 | |||
| 2012-12-31 | $0.00 derived: 10-K 9 month − 10-Q 6 month · filed 2013-03-18 | $0.00 derived: sum of 2 quarters · filed 2013-03-18 | $762.67K 10-K · filed 2013-03-18 | |
| 2012-09-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2012-11-13 | $762.67K 10-Q · filed 2012-11-13 | ||
| 2012-06-30 | $762.67K 10-Q · filed 2012-08-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| Sunshine Biopharma Inc. (SBFM) | $0.003B | ||
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| ORAGENICS INC (OGEN) | United States | $0.002B |